Herbs (Global Traditional) · European
Verbena officinalis
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Verbena officinalis contains bioactive compounds like verbenalin and iridoid glycosides that demonstrate anti-inflammatory and immunomodulatory properties. The herb's primary mechanism involves modulation of inflammatory cytokines and enhancement of natural killer cell activity.
Verbena officinalis L., commonly known as common vervain, is a perennial herb native to Europe, Asia, and North America, belonging to the Verbenaceae family. The aerial parts are harvested during flowering and prepared as aqueous decoctions, infusions, or lyophilized extracts. The herb contains iridoid glycosides (including verbenalin), phenylethanoid glycosides, terpenes, and polysaccharides.
Clinical evidence is limited to one double-blind randomized controlled multicenter trial (PMID: 26824082) testing V. officinalis decoction as a mouth rinse in 60 patients with chronic generalized gingivitis, showing significant improvements at days 14 and 28. No human RCTs exist for systemic uses; other evidence comes from animal and in vitro studies using 200 mg/kg oral doses.
Clinical trial: V. officinalis decoction used as mouth rinse twice daily for 28 days. Animal studies: 200 mg/kg body weight daily of lyophilized or aqueous extract for systemic effects. No standardized human systemic dosage established from clinical trials. Consult a healthcare provider before starting any new supplement.
Verbena officinalis is used primarily as a medicinal herb rather than a food source, so macronutrient data per serving is minimal (negligible calories, protein, fat, and carbohydrates in typical tea or tincture preparations). Key bioactive compounds include: **Iridoid glycosides** – verbenalin (cornin, ~0.15–0.5% dry weight) and hastatoside (~0.1–0.3% dry weight), which are considered the principal pharmacologically active constituents responsible for anti-inflammatory and neuroprotective activity; **Phenylpropanoid glycosides** – verbascoside (acteoside, ~0.5–3.5% dry weight depending on harvest time and plant part), a potent antioxidant with documented high radical-scavenging capacity (ORAC values comparable to or exceeding many polyphenol-rich herbs); **Flavonoids** – including apigenin, luteolin, and their glycosides (scutellarein-7-glucoside, pedalitin), present at approximately 0.1–0.5% dry weight collectively, contributing to anti-inflammatory and mild anxiolytic effects; **Triterpenoids** – ursolic acid and oleanolic acid (trace to ~0.2% dry weight); **Phenolic acids** – caffeic acid, chlorogenic acid, and rosmarinic acid (trace amounts); **Essential oil** – present in very low concentration (~0.01–0.03%), containing citral, geraniol, and limonene among other monoterpenes; **Tannins** – approximately 2–5% dry weight; **Mucilage and polysaccharides** – minor amounts contributing to soothing effects on mucosal tissues. **Minerals**: Iron, calcium, and manganese are present in modest amounts typical of dried herbs (e.g., calcium ~800–1200 mg/100 g dry herb, iron ~15–30 mg/100 g dry herb), though the quantities consumed in a standard infusion (1–3 g dried herb) contribute only trace dietary mineral intake. **Vitamins**: Small amounts of vitamin C and beta-carotene have been reported but are not nutritionally significant at typical dosing. **Bioavailability notes**: Verbascoside undergoes extensive first-pass metabolism; oral bioavailability in humans is estimated at <5%, with hydroxytyrosol and caffeic acid as primary circulating metabolites. Verbenalin is relatively water-soluble and extractable by hot-water infusion (~60–80% extraction efficiency), while flavonoid aglycones are better extracted with hydroalcoholic preparations. Bioavailability of ursolic acid is low (~1–2%) due to poor aqueous solubility. Co-administration with lipids or use of tincture formulations may modestly improve absorption of lipophilic constituents.
Verbena officinalis exerts its effects primarily through verbenalin, which modulates inflammatory pathways by inhibiting pro-inflammatory cytokines like TNF-α and IL-1β. The compound enhances natural killer (NK) cell cytotoxicity through activation of perforin and granzyme pathways. Iridoid glycosides in the plant also contribute to anti-inflammatory activity by suppressing NF-κB signaling cascades.
A randomized controlled trial with 60 participants demonstrated significant improvements in Gingival Index and Plaque Index scores in chronic gingivitis patients using Verbena officinalis, with statistical significance (p<0.05) and no reported adverse effects. Animal studies show verbenalin enhances NK cell killing efficiency against influenza viruses. However, human clinical evidence remains limited, with most research consisting of preliminary animal studies and small-scale trials. Additional large-scale human studies are needed to establish comprehensive therapeutic efficacy.
Verbena officinalis is generally well-tolerated with no significant adverse effects reported in clinical studies. The herb may interact with anticoagulant medications due to potential blood-thinning properties, requiring medical supervision. Pregnancy and breastfeeding safety has not been established through adequate clinical research. Individuals with autoimmune conditions should exercise caution due to the herb's immune-stimulating effects.
